Cargando…
Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia
During pathological pain, the actions of the endocannabinoid system, including the cannabinoid 2 receptor (CB(2)R), leads to effective anti-allodynia and modifies a variety of spinal microglial and astrocyte responses. Here, following spinal administration of the CB(2)R compound, AM1241, we examined...
Autores principales: | Wilkerson, Jenny L, Gentry, Katherine R, Dengler, Ellen C, Wallace, James A, Kerwin, Audra A, Kuhn, Megan N, Zvonok, Alexander M, Thakur, Ganesh A, Makriyannis, Alexandros, Milligan, Erin D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345359/ https://www.ncbi.nlm.nih.gov/pubmed/22574283 http://dx.doi.org/10.1002/brb3.44 |
Ejemplares similares
-
Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain
por: Wilkerson, Jenny L., et al.
Publicado: (2020) -
Pretreatment with AM1241 Enhances the Analgesic Effect of Intrathecally Administrated Mesenchymal Stem Cells
por: Xie, Junran, et al.
Publicado: (2019) -
Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor
por: Mallipeddi, Srikrishnan, et al.
Publicado: (2018) -
Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain
por: Dengler, Ellen C, et al.
Publicado: (2014) -
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
por: Rahn, Elizabeth J, et al.
Publicado: (2014)